Literature DB >> 27389665

Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.

Nicola Dalbeth1, Hyon K Choi2, Robert Terkeltaub3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27389665      PMCID： PMC5195886          DOI： 10.1002/art.39799

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  86 in total

1.  Cost-effectiveness of allopurinol and febuxostat for the management of gout.

Authors:  Eric Jutkowitz; Hyon K Choi; Laura T Pizzi; Karen M Kuntz
Journal:  Ann Intern Med       Date:  2014-11-04       Impact factor: 25.391

Review 2.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

3.  Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial.

Authors:  Timothy Hudson Rainer; Chi Hung Cheng; Hein J E M Janssens; Chi Yin Man; Lai Shan Tam; Yu Fai Choi; Wah Hon Yau; Ka Hing Lee; Colin Alexander Graham
Journal:  Ann Intern Med       Date:  2016-02-23       Impact factor: 25.391

Review 4.  Medication adherence in gout: a systematic review.

Authors:  Mary A De Vera; Greg Marcotte; Sharan Rai; Jessica S Galo; Vidula Bhole
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

5.  2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Authors:  Dinesh Khanna; Puja P Khanna; John D Fitzgerald; Manjit K Singh; Sangmee Bae; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

6.  Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.

Authors:  Fernando Perez-Ruiz; Marcelo Calabozo; Jose I Pijoan; Ana M Herrero-Beites; Ana Ruibal
Journal:  Arthritis Rheum       Date:  2002-08

7.  Independent impact of gout on mortality and risk for coronary heart disease.

Authors:  Hyon K Choi; Gary Curhan
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690

8.  Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.

Authors:  Na Lu; Sharan K Rai; Robert Terkeltaub; Seoyoung C Kim; Mariano E Menendez; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-03-31       Impact factor: 5.532

9.  Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study.

Authors:  Robert D Goldfien; Michele S Ng; Goldie Yip; Alice Hwe; Alice Jacobson; Alice Pressman; Andrew L Avins
Journal:  BMJ Open       Date:  2014-01-10       Impact factor: 2.692

Review 10.  Why does the gout attack stop? A roadmap for the immune pathogenesis of gout.

Authors:  Georg Schett; Christine Schauer; Markus Hoffmann; Martin Herrmann
Journal:  RMD Open       Date:  2015-08-15
View more
  11 in total

1.  Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1β Production.

Authors:  Marwa Qadri; Sandy ElSayed; Khaled A Elsaid
Journal:  J Pharmacol Exp Ther       Date:  2020-11-25       Impact factor: 4.030

Review 2.  Gout: An old disease in new perspective - A review.

Authors:  Gaafar Ragab; Mohsen Elshahaly; Thomas Bardin
Journal:  J Adv Res       Date:  2017-05-10       Impact factor: 10.479

Review 3.  What makes gouty inflammation so variable?

Authors:  Robert Terkeltaub
Journal:  BMC Med       Date:  2017-08-18       Impact factor: 8.775

Review 4.  How Can We Improve Disease Education in People with Gout?

Authors:  Theodore R Fields; Adena Batterman
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

5.  Patterns of health care utilization of gout patients in Hawai'i-high rates of emergency department utilization as compared to rheumatoid arthritis.

Authors:  Victoria P Mak; Andrea M Siu; So Yung Choi; Hyeong Jun Ahn; Sian Yik Lim
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

6.  Association of Serum Uric Acid with Cardiovascular Disease Risk Scores in Koreans.

Authors:  Seung Yun Lee; Won Park; Young Ju Suh; Mie Jin Lim; Seong-Ryul Kwon; Joo-Hyun Lee; Young Bin Joo; Youn-Kyung Oh; Kyong-Hee Jung
Journal:  Int J Environ Res Public Health       Date:  2019-11-21       Impact factor: 3.390

7.  Design and Biological Evaluation of Colchicine-CD44-Targeted Peptide Conjugate in an In Vitro Model of Crystal Induced Inflammation.

Authors:  Khalid A Zoghebi; Emira Bousoik; Keykavous Parang; Khaled A Elsaid
Journal:  Molecules       Date:  2019-12-21       Impact factor: 4.411

8.  Estimation of Primary Prevention of Gout in Men Through Modification of Obesity and Other Key Lifestyle Factors.

Authors:  Natalie McCormick; Sharan K Rai; Na Lu; Chio Yokose; Gary C Curhan; Hyon K Choi
Journal:  JAMA Netw Open       Date:  2020-11-02

9.  CD44 Receptor Mediates Urate Crystal Phagocytosis by Macrophages and Regulates Inflammation in A Murine Peritoneal Model of Acute Gout.

Authors:  Emira Bousoik; Marwa Qadri; Khaled A Elsaid
Journal:  Sci Rep       Date:  2020-04-01       Impact factor: 4.379

10.  Resveratrol Relieves Gouty Arthritis by Promoting Mitophagy to Inhibit Activation of NLRP3 Inflammasomes.

Authors:  Weimin Fan; Shixian Chen; Xianghui Wu; Junqing Zhu; Juan Li
Journal:  J Inflamm Res       Date:  2021-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.